Aliases & Classifications for Cerebral Hemorrhage

MalaCards integrated aliases for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 39 30

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy, app-related and cerebral amyloid angiopathy, cst3-related, and has symptoms including seizures, tremor and angina pectoris. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and MSP-RON Signaling. The drugs Aspirin and Probucol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and testes, and related phenotypes are cardiovascular system and muscle

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 208)
# Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy, app-related 33.7 APP CST3
2 cerebral amyloid angiopathy, cst3-related 33.6 APP CST3
3 hemorrhage, intracerebral 32.5 APP CST3
4 hereditary cerebral amyloid angiopathy 29.9 APP CST3
5 brain edema 29.6 GFAP IL1B
6 encephalitis 29.5 GFAP IL1B
7 alzheimer disease 29.4 APP CST3 GFAP IL1B
8 arteries, anomalies of 29.4 APOB IL1B
9 heart disease 29.1 APOB CST3 IL1B
10 myocardial infarction 29.0 APOB CST3 IL1B
11 eclampsia 11.4
12 cerebral cavernous malformation, familial 11.2
13 cerebral cavernous malformations 11.0
14 thrombocytopenia 1 11.0
15 amyloidosis 10.5
16 thrombosis 10.1
17 endocarditis 10.1
18 prion disease 10.1 APP IL1B
19 peripheral artery disease 10.1 APOB CST3
20 vascular dementia 10.1 APP CST3
21 stroke, ischemic 10.1
22 leukemia 10.1
23 end stage renal failure 10.0 APOB CST3
24 infective endocarditis 10.0
25 ischemia 10.0
26 brain injury 9.9
27 thrombocytopenia 9.9
28 dementia 9.9
29 glucose metabolism disease 9.9 APOB IL1B
30 acquired metabolic disease 9.9 APOB IL1B
31 binswanger's disease 9.9 APP GFAP
32 scrapie 9.9 APP GFAP
33 choriocarcinoma 9.9
34 cerebrovascular disease 9.9
35 encephalopathy 9.9
36 leukoencephalopathy, hereditary diffuse, with spheroids 9.9 APP GFAP
37 systemic lupus erythematosus 9.8
38 pheochromocytoma 9.8
39 moyamoya disease 1 9.8
40 acute promyelocytic leukemia 9.8
41 traumatic brain injury 9.8
42 angiosarcoma 9.8
43 cerebral artery occlusion 9.8
44 sarcoma 9.8
45 arteriovenous malformation 9.8
46 purpura 9.8
47 lupus erythematosus 9.8
48 meningitis 9.8
49 hemophilia 9.8
50 rere-related disorders 9.8

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

UMLS symptoms related to Cerebral Hemorrhage:


seizures, tremor, angina pectoris, edema, back pain, pain, chest pain, headache, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 APOB APP CST3 GFAP IL1B
2 muscle MP:0005369 8.92 APOB APP CST3 GFAP

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 375)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
2
Probucol Approved, Investigational Phase 4 23288-49-5 4912
3
Cilostazol Approved, Investigational Phase 4,Not Applicable 73963-72-1 2754
4
Enoxaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 55985-32-5 4474
6
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 772 46507594
7
Dalteparin Approved Phase 4,Phase 2,Not Applicable 9005-49-6
8
Nadroparin Approved, Investigational Phase 4
9
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
10
Cisatracurium Approved Phase 4,Not Applicable 96946-41-7
11
Phylloquinone Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 84-80-0
12
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 6691 54678486
13
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1401-55-4
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
15
Simvastatin Approved Phase 4,Phase 2,Not Applicable 79902-63-9 54454
16
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
17
Etomidate Approved Phase 4,Not Applicable 33125-97-2 36339 667484
18
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
19
Midazolam Approved, Illicit Phase 4,Not Applicable 59467-70-8 4192
20
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
21
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
22
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 453 6251
23
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
24
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 120202-66-6, 113665-84-2 60606
25
Caffeine Approved Phase 4,Phase 1,Phase 2 58-08-2 2519
26
Sodium Citrate Approved, Investigational Phase 4 68-04-2
27
Ticagrelor Approved Phase 4 274693-27-5 9871419
28
Amlodipine Approved Phase 4,Phase 3,Not Applicable 88150-42-9 2162
29
Angiotensin II Approved, Investigational Phase 4,Phase 3,Not Applicable 68521-88-0, 11128-99-7, 4474-91-3 172198 65143
30
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 130881 158781
31
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
32
Pitavastatin Approved Phase 4 147526-32-7, 147511-69-1 6366718 5282452
33
Ezetimibe Approved Phase 4 163222-33-1 150311
34
Succinylcholine Approved Phase 4,Not Applicable 306-40-1 5314
35
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
36
Atorvastatin Approved Phase 4,Not Applicable 134523-00-5 60823
37
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10102-43-9 145068
38
Esmolol Approved Phase 4,Phase 3,Not Applicable 103598-03-4, 81147-92-4 59768
39
Nitroprusside Approved, Investigational Phase 4,Phase 3,Not Applicable 15078-28-1 11963622
40
Betamethasone Approved, Vet_approved Phase 4,Not Applicable 378-44-9 9782
41
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
42
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
43
Desflurane Approved Phase 4 57041-67-5 42113
44
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
45
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
46
Losartan Approved Phase 4 114798-26-4 3961
47
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
48
Tirofiban Approved Phase 4 144494-65-5 60947
49
carbamide peroxide Approved Phase 4 124-43-6
50
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440

Interventional clinical trials:

(show top 50) (show all 535)
# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
4 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
7 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
8 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
9 The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Unknown status NCT02870764 Phase 4 Dan-shen extract;Placebo
10 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
11 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
12 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
13 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
14 Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study Completed NCT03847883 Phase 4 Intravenous Solution Ateplase
15 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed NCT00234065 Phase 4 Cilostazol;Aspirin
16 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
17 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
18 Clopidogrel for Acute Ischaemia of Recent Onset Completed NCT02776540 Phase 4 Clopidogrel;Aspirin
19 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
20 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
21 A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting Completed NCT02330640 Phase 4 ticagrelor;clopidogrel;asprin
22 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
23 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
24 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
25 Continuous Glucose Monitoring and Preterm Infants Completed NCT02583776 Phase 4
26 Cilostazol Stroke Prevention Study for Antiplatelet Combination Completed NCT01995370 Phase 4 aspirin;clopidogrel;cilostazol
27 Study of Heart and Renal Protection Completed NCT00125593 Phase 4 Simvastatin 20 mg;Ezetimibe 10mg;Placebo
28 Danhong Injection in the Treatment of Chronic Stable Angina Completed NCT01681316 Phase 4 Danhong injection;Placebo
29 Study of Antithrombotic Treatment After IntraCerebral Haemorrhage Recruiting NCT03186729 Phase 4 Antithrombotic Agent
30 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
31 Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial Recruiting NCT03772847 Phase 4 ginkgolide
32 Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke Recruiting NCT03661411 Phase 4 Aspirin;Clopidogrel 75mg;Alteplase
33 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
34 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
35 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Recruiting NCT03417388 Phase 4 High dose potent statin;ACE-I (lisinopril) or ARB (losartan);Aspirin
36 Danhong Injection in the Treatment of Acute Ischemic Stroke Recruiting NCT01677208 Phase 4 Danhong injection;placebo
37 ASCEND: A Study of Cardiovascular Events iN Diabetes Active, not recruiting NCT00135226 Phase 4 aspirin;Omega-3-acid Ethyl Esters;Placebo Aspirin;Placebo omega-3-Ethyl Esters
38 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
39 Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS) Not yet recruiting NCT03743103 Phase 4 Brevibloc, 10 Mg/mL Intravenous Solution;Nitroprusside, Sodium
40 Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes Not yet recruiting NCT03264352 Phase 4 Allisartan Isoproxil;Amlodipine 5mg;Hydrochlorothiazide 25 mg;Allisartan Isoproxil placebo;Amlodipine placebo;Hydrochlorothiazide placebo
41 Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction Not yet recruiting NCT03797729 Phase 4 Tirofiban;Normal saline
42 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
43 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
44 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Withdrawn NCT01042574 Phase 4 Clevidipine butyrate
45 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
46 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
47 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
48 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
49 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3
50 Management of Hypotension In the Preterm Infant Unknown status NCT01482559 Phase 3 Dopamine hydrochloride;Dextrose 5%

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads�, encapsulated mesenchymal stem cells for intracerebral hemorrhage
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Genetic tests related to Cerebral Hemorrhage:

# Genetic test Affiliating Genes
1 Cerebral Hemorrhage 30

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

42
Brain, Heart, Testes, Kidney, Bone, Lung, Bone Marrow

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 684)
# Title Authors Year
1
Tristetraprolin attenuates brain edema in a rat model of cerebral hemorrhage. ( 30729695 )
2019
2
Ultrasonography Monitoring of Optic Nerve Sheath Diameter and Retinal Vessels in Patients with Cerebral Hemorrhage. ( 30714259 )
2019
3
Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review. ( 30741383 )
2019
4
Radial Dislocation of Extensor Tendon Over the Metacarpophalangeal Joint of the Thumb due to Cerebral Hemorrhage: A Case Report. ( 30760160 )
2019
5
Rehabilitation training combined acupuncture for limb hemiplegia caused by cerebral hemorrhage: A protocol for a systematic review of randomized controlled trial. ( 30817621 )
2019
6
Original Intracerebral Hemorrhage Score for the Prediction of Short-Term Mortality in Cerebral Hemorrhage: Systematic Review and Meta-Analysis. ( 30889025 )
2019
7
Clinical Features of Nephrotic Syndrome with Cerebral Hemorrhage. ( 30904921 )
2019
8
Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage. ( 30421455 )
2019
9
Previous chronic symptomatic and asymptomatic cerebral hemorrhage in patients with acute ischemic stroke. ( 30488255 )
2019
10
Time-effect relationship of acupuncture on histopathology, ultrastructure, and neuroethology in the acute phase of cerebral hemorrhage. ( 30531084 )
2019
11
Comparison of keyhole endoscopy and craniotomy for the treatment of patients with hypertensive cerebral hemorrhage. ( 30633227 )
2019
12
Fenobucarb induces heart failure and cerebral hemorrhage in zebrafish. ( 30685545 )
2019
13
Experimental study on the detection of cerebral hemorrhage in rabbits based on broadband antenna technology. ( 30689436 )
2019
14
The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage. ( 30698226 )
2019
15
Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. ( 29844891 )
2018
16
Related Factors of Early Mortality in Young Adults with Cerebral Hemorrhage. ( 29915811 )
2018
17
Response by Fouda and Switzer to Letter Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183950 )
2018
18
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility. ( 29017932 )
2018
19
Lethal cerebral hemorrhage after ticagrelor intoxication: a specific antidote is urgently needed. ( 29889575 )
2018
20
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa I^-related pathway in rats. ( 29928110 )
2018
21
Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. ( 29643882 )
2018
22
Cerebral Venous Sinus Thrombosis with Cerebral Hemorrhage Presenting with Status Epilepticus in Early Pregnancy. ( 29739085 )
2018
23
Recurrent Cerebral Hemorrhage in Normal Pregnancy Secondary to Mycotic Pseudoaneurysms Related to Choriocarcinoma. ( 28987845 )
2018
24
Fetal Cerebral Hemorrhage due to X-linked GATA1 gene mutation. ( 29949202 )
2018
25
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). ( 29433151 )
2018
26
Relationship Between Short Term Variability (STV) and Onset of Cerebral Hemorrhage at Ischemia-Reperfusion Load in Fetal Growth Restricted (FGR) Mice. ( 29867536 )
2018
27
Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials. ( 29929173 )
2018
28
Fatal cerebral hemorrhage in a tetraplegic patient due to autonomic dysreflexia triggered by delay in emptying urinary bladder after unsuccessful intermittent catheterization by carer: lessons learned. ( 29563843 )
2018
29
Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation. ( 29928111 )
2018
30
Letter by Chang et al Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183951 )
2018
31
Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. ( 29737222 )
2018
32
A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. ( 29566704 )
2018
33
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. ( 29247070 )
2018
34
Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type. ( 29706885 )
2018
35
Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage. ( 30027390 )
2018
36
Impact of Supratentorial Cerebral Hemorrhage on the Complexity of Heart Rate Variability in Acute Stroke. ( 30065287 )
2018
37
SP100B Expression Indexed Hemorrhage in Mouse Models of Cerebral Hemorrhage. ( 30072838 )
2018
38
Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review. ( 30090954 )
2018
39
Acute Blood Pressure Management in Acute Ischemic Stroke and Spontaneous Cerebral Hemorrhage. ( 30121736 )
2018
40
A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn. ( 30151288 )
2018
41
Catastrophic cerebral hemorrhage and edema in a patient with pneumococcal meningitis. ( 30216857 )
2018
42
Comparison of Thrombelastography (TEG) in Patients with Acute Cerebral Hemorrhage and Cerebral Infarction. ( 30217969 )
2018
43
MiR-7 alleviates secondary inflammatory response of microglia caused by cerebral hemorrhage through inhibiting TLR4 expression. ( 30229834 )
2018
44
Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside. ( 30254628 )
2018
45
Large B-cell lymphoma concommittant to intra-cerebral hemorrhage. ( 30500092 )
2018
46
Correlations of Acute Cerebral Hemorrhage Complicated with Stress Ulcer Bleeding with Acute Physiology and Chronic Health Evaluation (APACHE) II Score, Endothelin (ET), Tumor Necrosis Factor-alpha (TNF-α), and Blood Lipids. ( 30554231 )
2018
47
The Effects of Filgrastim on Complications of Patients with Cerebral Hemorrhage Due To Head Trauma. ( 30559855 )
2018
48
Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy. ( 28090058 )
2017
49
Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. ( 28524787 )
2017
50
Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. ( 28342065 )
2017

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.87 APP CST3 GFAP
2 10.64 IL1B KLK1
3 9.98 APP CST3

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.72 APOB APP CST3 IL1B KLK1
2 endoplasmic reticulum lumen GO:0005788 9.43 APOB APP CST3
3 secretory granule GO:0030141 9.37 IL1B KLK1
4 smooth endoplasmic reticulum GO:0005790 9.16 APOB APP
5 endosome lumen GO:0031904 8.96 APOB APP
6 astrocyte projection GO:0097449 8.62 APP GFAP

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.58 APOB APP IL1B
2 positive regulation of DNA-binding transcription factor activity GO:0051091 9.49 APP IL1B
3 cholesterol metabolic process GO:0008203 9.46 APOB APP
4 positive regulation of JNK cascade GO:0046330 9.43 APP IL1B
5 post-translational protein modification GO:0043687 9.43 APOB APP CST3
6 cellular protein metabolic process GO:0044267 9.33 APOB APP CST3
7 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.32 APP IL1B
8 response to estradiol GO:0032355 9.18 APOB
9 negative regulation of neuron differentiation GO:0045665 9.07 APP
10 positive regulation of glial cell proliferation GO:0060252 8.96 GFAP IL1B
11 response to carbohydrate GO:0009743 8.62 APOB IL1B

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....